KNSA - Kiniksa Pharmaceuticals International Plc Forecast, Target Price

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ALKS INDV LNTH NBIX ACAD BMRN AXSM BIIB INCY VRTX

| Held by: VTI VB VBK DFAS DFMC VHT DFAC AVSC FDLS FFSM

Scroll to Statements

Index	-	P/E	55.00	EPS (ttm)	0.91	Insider Own	43.67%	Shs Outstand	46.05M	Perf Week	4.29%
Market Cap	3.84B	Forward P/E	26.06	EPS next Y	1.91	Insider Trans	-2.37%	Shs Float	43.34M	Perf Month	-14.50%
Enterprise Value	3.38B	PEG	0.53	EPS next Q	0.31	Inst Own	59.45%	Short Float	7.02%	Perf Quarter	7.76%
Income	73.06M	P/S	5.09	EPS this Y	82.96%	Inst Trans	3.37%	Short Ratio	4.53	Perf Half Y	20.11%
Sales	754.04M	P/B	6.32	EPS next Y	39.55%	ROA	10.26%	Short Interest	3.04M	Perf YTD	20.98%
Book/sh	7.90	P/C	8.20	EPS next 5Y	49.30%	ROE	13.74%	52W High	59.87 -16.64%	Perf Year	67.64%
Cash/sh	6.08	P/FCF	23.38	EPS past 3/5Y	-34.04% -	ROIC	11.95%	52W Low	26.27 89.97%	Perf 3Y	231.59%
Dividend Est.	-	EV/EBITDA	35.63	Sales past 3/5Y	45.45% -	Gross Margin	54.61%	Volatility	4.06% 3.90%	Perf 5Y	236.51%
Dividend TTM	-	EV/Sales	4.48	EPS Y/Y TTM	509.31%	Oper. Margin	12.36%	ATR (14)	2.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.33	Sales Y/Y TTM	56.71%	Profit Margin	9.69%	RSI (14)	46.54	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.79	EPS Q/Q	144.51%	SMA20	-3.54%	Beta	0.13	Target Price	63.50
Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	55.51%	SMA50	-1.35%	Rel Volume	0.34	Prev Close	48.70
Employees	366	LT Debt/Eq	0.01	Earnings	Apr 28 BMO	SMA200	14.99%	Avg Volume	671.44K	Price	49.90
IPO	May 24, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	33.80% 3.96%	Trades		Volume	96,056	Change	2.47%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)